Gossamer Bio Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Gossamer Bio Inc GOSS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 12.92 20:00:00
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
12.92 13.38 0.46 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 12.92 USD


Draw Mode:

Gossamer Bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 981.84M 75.99M 63.84M $ - $ - -3.55 -3.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 234.50k 2.20%

more financials information »

Gossamer Bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GOSS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week10.5114.1010.5112.32987,6912.4122.93%
1 Month9.9714.109.550111.10631,3142.9529.59%
3 Months8.4914.107.049.39523,8984.4352.18%
6 Months9.1514.107.048.99533,6193.7741.2%
1 Year12.3514.107.049.61668,7410.574.62%
3 Years18.7227.14977.0413.00539,602-5.80-30.98%
5 Years18.7227.14977.0413.00539,602-5.80-30.98%

Gossamer Bio Description

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH(pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Your Recent History
Gossamer B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.